Total Funding
5
59
Total FundingDebt Financing raised
Growth Score
4 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
17199
PharmaCann is a vertically-integrated and unified medical cannabis company changing the way people view cannabis.
Jeff Langenbach: Chief Development OfficerPast Role: Apollo Education Group, Senior Vice President of Strategy & Business Development
Gregory W. Cappelli: Executive ChairmanPast Role: Apollo Education Group, Chief Executive Officer
About the Company
PharmaCann is a vertically-integrated and unified medical cannabis company changing the way people view cannabis. The company is providing safe, reliable, top-quality cannabis products to improve people’s lives. By investing in people, practices, and infrastructure, they are shaping a new, vital, wellness-focused industry. Their goal is to increase
sustainable access to cannabis by offering effective, affordable, and trusted products and services.
It was founded in 2014 and is headquartered in Oak Park, Illinois.
